SEC Form 4 · accession 0000899243-18-011952
Amneal Pharmaceuticals, Inc. · AMRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
APHC Holdings, LLC
10% Owner
Period of report
May 4, 2018
Accepted (ET)
May 8, 2018 · 7:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001723128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | May 4, 2018 | C | 41,406,689 | $0.00 | A | 41,406,689 | D | |
| Class B-1 Common Stock | May 4, 2018 | C | 12,328,767 | $0.00 | A | 12,328,767 | D | |
| Class A Common Stock | May 4, 2018 | S | 34,520,549 | $18.25 | D | 6,886,140 | D | |
| Class B-1 Common Stock | May 4, 2018 | S | 12,328,767 | $18.25 | D | 0 | D | |
| Class B Common Stock | May 4, 2018 | J | 53,735,465 | $0.00 | D | 171,260,707 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common UnitsF2 | — | May 4, 2018 | C | 41,406,689 | D | — | — | Class A Common Stock | 41,406,689 | 183,589,474 | D |
| Common UnitsF2 | — | May 4, 2018 | C | 12,328,767 | D | — | — | Class B-1 Common Stock | 12,328,767 | 171,260,707 | D |
Explanation of responses
- F1Reflects the cancellation for no consideration of Class B Common Stock in connection with the redemption of the Common Units.
- F2The Common Units may be redeemed by the Reporting Person at any time for shares of the Issuer's Class A Common Stock or Class B-1 Common Stock on a 1-to-1 basis.